Page last updated: 2024-10-31

n-benzyl-1-aminobenzotriazole and Respiratory Distress Syndrome

n-benzyl-1-aminobenzotriazole has been researched along with Respiratory Distress Syndrome in 1 studies

Respiratory Distress Syndrome: A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA.

Research Excerpts

ExcerptRelevanceReference
"Exposure of vehicle-treated rats to hyperoxia led to 6."1.31Potentiation of oxygen-induced lung injury in rats by the mechanism-based cytochrome P-450 inhibitor, 1-aminobenzotriazole. ( Bend, JR; Moorthy, B; Parker, KM; Smith, CV; Welty, SE, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Moorthy, B1
Parker, KM1
Smith, CV1
Bend, JR1
Welty, SE1

Other Studies

1 other study available for n-benzyl-1-aminobenzotriazole and Respiratory Distress Syndrome

ArticleYear
Potentiation of oxygen-induced lung injury in rats by the mechanism-based cytochrome P-450 inhibitor, 1-aminobenzotriazole.
    The Journal of pharmacology and experimental therapeutics, 2000, Volume: 292, Issue:2

    Topics: Animals; Blotting, Western; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 Enzym

2000